366 related articles for article (PubMed ID: 22336585)
1. Inhibition of the Rho/ROCK pathway enhances the efficacy of cisplatin through the blockage of hypoxia-inducible factor-1α in human ovarian cancer cells.
Ohta T; Takahashi T; Shibuya T; Amita M; Henmi N; Takahashi K; Kurachi H
Cancer Biol Ther; 2012 Jan; 13(1):25-33. PubMed ID: 22336585
[TBL] [Abstract][Full Text] [Related]
2. Fasudil-induced hypoxia-inducible factor-1alpha degradation disrupts a hypoxia-driven vascular endothelial growth factor autocrine mechanism in endothelial cells.
Takata K; Morishige K; Takahashi T; Hashimoto K; Tsutsumi S; Yin L; Ohta T; Kawagoe J; Takahashi K; Kurachi H
Mol Cancer Ther; 2008 Jun; 7(6):1551-61. PubMed ID: 18566226
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of RhoA/ROCK signaling pathway ameliorates hypoxic pulmonary hypertension via HIF-1α-dependent functional TRPC channels.
Wang XY; Mo D; Tian W; Liu XX; Zhou YG; Sun Y; Feng YD; Xiao X; Hao XW; Zhang HN; Li C; Cao W; Li XQ
Toxicol Appl Pharmacol; 2019 Apr; 369():60-72. PubMed ID: 30831131
[TBL] [Abstract][Full Text] [Related]
4. RhoA/ROCK pathway inhibition by fasudil suppresses the vasculogenic mimicry of U2OS osteosarcoma cells in vitro.
Xia Y; Cai X; Fan J; Zhang L; Li Z; Ren J; Wu G; Zhu F
Anticancer Drugs; 2017 Jun; 28(5):514-521. PubMed ID: 28225457
[TBL] [Abstract][Full Text] [Related]
5. The Effect of Ras Homolog C/Rho-Associated Coiled-Protein Kinase (Rho/ROCK) Signaling Pathways on Proliferation and Apoptosis of Human Myeloma Cells.
Feng X; Zhang L; Nie S; Zhuang L; Wang W; Huang J; Yan X; Meng F
Med Sci Monit; 2019 Oct; 25():7605-7616. PubMed ID: 31599230
[TBL] [Abstract][Full Text] [Related]
6. Rho-kinase inhibition prevents the progression of diabetic nephropathy by downregulating hypoxia-inducible factor 1α.
Matoba K; Kawanami D; Okada R; Tsukamoto M; Kinoshita J; Ito T; Ishizawa S; Kanazawa Y; Yokota T; Murai N; Matsufuji S; Takahashi-Fujigasaki J; Utsunomiya K
Kidney Int; 2013 Sep; 84(3):545-54. PubMed ID: 23615507
[TBL] [Abstract][Full Text] [Related]
7. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
8. The Rho kinase inhibitor fasudil inhibits tumor progression in human and rat tumor models.
Ying H; Biroc SL; Li WW; Alicke B; Xuan JA; Pagila R; Ohashi Y; Okada T; Kamata Y; Dinter H
Mol Cancer Ther; 2006 Sep; 5(9):2158-64. PubMed ID: 16985048
[TBL] [Abstract][Full Text] [Related]
9. Rho-kinase inhibitor, fasudil, suppresses glioblastoma cell line progression in vitro and in vivo.
Deng L; Li G; Li R; Liu Q; He Q; Zhang J
Cancer Biol Ther; 2010 Jun; 9(11):875-84. PubMed ID: 20364104
[TBL] [Abstract][Full Text] [Related]
10. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
11. The RhoA/ROCK Pathway Ameliorates Adhesion and Inflammatory Infiltration Induced by AGEs in Glomerular Endothelial Cells.
Rao J; Ye Z; Tang H; Wang C; Peng H; Lai W; Li Y; Huang W; Lou T
Sci Rep; 2017 Jan; 7():39727. PubMed ID: 28054559
[TBL] [Abstract][Full Text] [Related]
12. Effects of ethanol on RhoA/Rho-kinase-mediated calcium sensitization in mouse lung parenchymal tissue.
Aydinoglu F; Ergurhan Kiroglu O; Astarci E; Balli E; Ogulener N
Eur J Pharmacol; 2015 Oct; 764():318-327. PubMed ID: 26169563
[TBL] [Abstract][Full Text] [Related]
13. Hypoxic induction of vasculogenic mimicry in hepatocellular carcinoma: role of HIF-1 α, RhoA/ROCK and Rac1/PAK signaling.
Zhang JG; Zhou HM; Zhang X; Mu W; Hu JN; Liu GL; Li Q
BMC Cancer; 2020 Jan; 20(1):32. PubMed ID: 31931758
[TBL] [Abstract][Full Text] [Related]
14. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
15. Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control.
Kolavennu V; Zeng L; Peng H; Wang Y; Danesh FR
Diabetes; 2008 Mar; 57(3):714-23. PubMed ID: 18083785
[TBL] [Abstract][Full Text] [Related]
16. Could pharmacological curtailment of the RhoA/Rho-kinase pathway reverse the endothelial barrier dysfunction associated with Ebola virus infection?
Eisa-Beygi S; Wen XY
Antiviral Res; 2015 Feb; 114():53-6. PubMed ID: 25512227
[TBL] [Abstract][Full Text] [Related]
17. Overcoming cisplatin resistance of ovarian cancer cells by targeting HIF-1-regulated cancer metabolism.
Ai Z; Lu Y; Qiu S; Fan Z
Cancer Lett; 2016 Apr; 373(1):36-44. PubMed ID: 26801746
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
Mera C; Godoy I; Ramírez R; Moya J; Ocaranza MP; Jalil JE
Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):4-20. PubMed ID: 26490279
[TBL] [Abstract][Full Text] [Related]
19. Fasudil, an inhibitor of Rho-associated coiled-coil kinase, improves cognitive impairments induced by smoke exposure.
Xueyang D; Zhanqiang M; Chunhua M; Kun H
Oncotarget; 2016 Nov; 7(48):78764-78772. PubMed ID: 27791202
[TBL] [Abstract][Full Text] [Related]
20. Fasudil alleviates acetaminophen-induced liver injury via targeting Rhoa/ROCK signal pathway.
Ren X; Meng T; Ren X; Li X; Lu L
J Toxicol Sci; 2021; 46(6):255-262. PubMed ID: 34078832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
